287 related articles for article (PubMed ID: 16716166)
21. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis.
Greenberg SA; Pinkus JL; Pinkus GS; Burleson T; Sanoudou D; Tawil R; Barohn RJ; Saperstein DS; Briemberg HR; Ericsson M; Park P; Amato AA
Ann Neurol; 2005 May; 57(5):664-78. PubMed ID: 15852401
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of myositis in children.
Griffin TA; Reed AM
Curr Opin Rheumatol; 2007 Sep; 19(5):487-91. PubMed ID: 17762616
[TBL] [Abstract][Full Text] [Related]
23. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.
Bilgic H; Ytterberg SR; Amin S; McNallan KT; Wilson JC; Koeuth T; Ellingson S; Newman B; Bauer JW; Peterson EJ; Baechler EC; Reed AM
Arthritis Rheum; 2009 Nov; 60(11):3436-46. PubMed ID: 19877033
[TBL] [Abstract][Full Text] [Related]
25. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
[TBL] [Abstract][Full Text] [Related]
26. Enhanced CCR5+/CCR3+ T helper cell ratio in patients with active cutaneous lupus erythematosus.
Freutel S; Gaffal E; Zahn S; Bieber T; Tüting T; Wenzel J
Lupus; 2011 Oct; 20(12):1300-4. PubMed ID: 21844117
[TBL] [Abstract][Full Text] [Related]
27. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs.
Fernandez TD; Mayorga C; Torres MJ; Cornejo-Garcia JA; López S; Chaves P; Rondon C; Blanca M
Allergy; 2008 Jun; 63(6):712-9. PubMed ID: 18384452
[TBL] [Abstract][Full Text] [Related]
28. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.
Goldberg-Bittman L; Neumark E; Sagi-Assif O; Azenshtein E; Meshel T; Witz IP; Ben-Baruch A
Immunol Lett; 2004 Mar; 92(1-2):171-8. PubMed ID: 15081542
[TBL] [Abstract][Full Text] [Related]
29. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
[TBL] [Abstract][Full Text] [Related]
30. Detection of myxovirus resistance protein A in lichen planus lesions and its relationship to hepatitis C virus.
Shaker OG; Hantar N; El-Tahlawi S; El-Tawdi A; El-Hadidi H; Hantar S; El-Refai A; William R
Br J Dermatol; 2009 May; 160(5):980-3. PubMed ID: 19222461
[TBL] [Abstract][Full Text] [Related]
31. Resolving lesions in human cutaneous leishmaniasis predominantly harbour chemokine receptor CXCR3-positive T helper 1/T cytotoxic type 1 cells.
Geiger B; Wenzel J; Hantschke M; Haase I; Ständer S; von Stebut E
Br J Dermatol; 2010 Apr; 162(4):870-4. PubMed ID: 19906074
[TBL] [Abstract][Full Text] [Related]
32. CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis.
Agostini C; Calabrese F; Poletti V; Marcer G; Facco M; Miorin M; Cabrelle A; Baesso I; Zambello R; Trentin L; Semenzato G
Respir Res; 2005 Feb; 6(1):20. PubMed ID: 15725351
[TBL] [Abstract][Full Text] [Related]
33. CXCR3, IP-10, and Mig are required for CD4+ T cell recruitment during the DTH response to HSV-1 yet are independent of the mechanism for viral clearance.
Molesworth-Kenyon S; Mates A; Yin R; Strieter R; Oakes J; Lausch R
Virology; 2005 Mar; 333(1):1-9. PubMed ID: 15708587
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Henneken M; Dörner T; Burmester GR; Berek C
Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
[TBL] [Abstract][Full Text] [Related]
35. Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod.
Wenzel J; Uerlich M; Haller O; Bieber T; Tueting T
J Cutan Pathol; 2005 Apr; 32(4):257-62. PubMed ID: 15769273
[TBL] [Abstract][Full Text] [Related]
36. Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis.
Grassi M; Capello F; Bertolino L; Seia Z; Pippione M
Clin Exp Dermatol; 2009 Dec; 34(8):910-4. PubMed ID: 19456762
[TBL] [Abstract][Full Text] [Related]
37. Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus.
Wenzel J; Zahn S; Bieber T; Tüting T
Arch Dermatol Res; 2009 Jan; 301(1):83-6. PubMed ID: 18784932
[TBL] [Abstract][Full Text] [Related]
38. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
[TBL] [Abstract][Full Text] [Related]
39. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
Larrubia JR; Calvino M; Benito S; Sanz-de-Villalobos E; Perna C; Pérez-Hornedo J; González-Mateos F; García-Garzón S; Bienvenido A; Parra T
J Hepatol; 2007 Nov; 47(5):632-41. PubMed ID: 17560677
[TBL] [Abstract][Full Text] [Related]
40. The CD40/CD40 ligand system in the skin of patients with subacute cutaneous lupus erythematosus.
Caproni M; Torchia D; Antiga E; Giomi B; Mercuri M; Volpi W; Fabbri P
J Rheumatol; 2007 Dec; 34(12):2412-6. PubMed ID: 18050371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
